- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT04048772
CALM IVF (Creación de afiliaciones, aprendizaje y atención plena para pacientes de fertilización in vitro)
Creación de afiliaciones, aprendizaje y atención plena para pacientes de fertilización in vitro
The investigators have designed a psychoeducational group curriculum specifically for new in vitro fertilization (IVF) patients (both male and female) to improve their treatment knowledge, to allow them to engage more in their care, to offer a support network, to improve satisfaction, and to provide them with tools to help reduce their stress and anxiety while undergoing the IVF process. The investigators plan to have four to eight infertility patients and their partners participate in a group at a time, for which they will attend three 1-1.5 hour interactive sessions that are scheduled throughout their first IVF cycle. These sessions will provide additional time for discussion about treatment with providers, learning opportunities on topics of interest to fertility patients, and stress reduction techniques. They will do several surveys before and after the intervention for comparison, including assessment of quality of life, depression, anxiety, resilience, and a knowledge assessment. The investigators will also track the patients to see if they pursue additional treatment in the instance of a negative pregnancy test compared to patients undergoing the standard treatment. The investigators plan to recruit a control group that receives the standard of care treatment here at the University of Iowa.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Patients and their partners (if present and consenting) will be randomized in a 2:1 fashion to two different treatment arms: A) standard of care in vitro fertilization (IVF) at the investigational institution as well as participating in an additional psychoeducational group or B) standard of care IVF at the investigational institution. The intervention group will consist of three additional evening visits for 1-1.5 hours per session. The sessions will include an interactive educational component addressing usual questions and concerns of IVF patients, such as reviewing common IVF myths, and also more information regarding treatment and technologies. Each session will also include teaching of coping strategies (such as awaiting the pregnancy test, how to cope with insensitive remarks from friends and family) as well as relaxation exercises, such as progressive muscle relaxation and deep breathing.
The patients will be consented at their new IVF visit and will take their initial assessments (FertiQoL, GAD-7, PHQ-9, the Connor-Davidson Resilience Scale, and a knowledge assessment) within 24 hours of the new visit. The patients will be assigned into groups based on when they are going through their IVF stimulations, so they will have similar experiences at similar times. Patients will take their final assessments on the third day after egg retrieval, regardless of group assignment.
When partners are present and consent to the study, they will be treated as a dyad with the patient undergoing oocyte retrieval. Some patients go through treatment alone (i.e. single adults desiring pregnancy) and therefore may not have a partner available to participate. Partners level of involvement in a cycle may very, as may their desire to participate in a psychosocial intervention. As patients and their partners make joint decisions throughout their IVF cycle and the cycle itself has a single outcome, we enrolled partners as dyads with patients when partners were present, but did not require a partner to enroll a patient.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Iowa
-
Iowa City, Iowa, Estados Unidos, 52242
- University of Iowa Hospitals and Clinics
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- All patients starting their first in vitro fertilization cycle at the University of Iowa Hospitals and Clinics
Exclusion Criteria:
- Patients who have already undergone in vitro fertilization treatment at any institution
- Non-English speakers
- Fertility preservation patients
- Patients using donor oocytes, embryos, or sperm
- Patients taking psychotropic medications for depression or anxiety that have had a dosing adjustment within 3 months of study enrollment
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Intervention
Standard of care in vitro fertilization patients randomized to the psychoeducational group intervention. |
The intervention will be three 1-1.5 hour interactive sessions that are scheduled throughout the participant's first in vitro fertilization cycle. These sessions will provide additional time for discussion about treatment with providers, learning opportunities on topics of interest to fertility patients, and stress reduction techniques. |
|
Otro: Control
Standard of care in vitro fertilization patients at our institution. |
Patients will receive the standard of care IVF treatment at the University of Iowa. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in female fertility patient quality of life score during IVF treatment cycle
Periodo de tiempo: From enrollment to 2-4 days after oocyte retrieval
|
FertiQoL International (Fertility Quality of Life Questionnaire 2008), scored scale from 0-100, with higher values indicating a higher quality of life and low scores indicating a lower quality of life. |
From enrollment to 2-4 days after oocyte retrieval
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in female GAD-7 score during IVF treatment cycle
Periodo de tiempo: From enrollment to 2-4 days after oocyte retrieval
|
Generalized Anxiety Disorder 7-item scale, with higher scores indicating higher likelihood of an anxiety disorder and lower scores indicating less likelihood of an anxiety disorder. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in female PHQ-9 score during IVF treatment cycle
Periodo de tiempo: From enrollment to 2-4 days after oocyte retrieval
|
Patient Health Questionnaire, with higher score indicating increased likelihood of a depressive disorder and lower scores indicating less likelihood of a depressive disorder. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in female Connor-Davidson Resilience Scale during IVF treatment cycle
Periodo de tiempo: From enrollment to 2-4 days after oocyte retrieval
|
Connor-Davidson Resilience Scale, with higher scores indicating greater resilience, and lower scores indicating lower resilience |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in female knowledge assessment during IVF treatment cycle
Periodo de tiempo: From enrollment to 2-4 days after oocyte retrieval
|
Assessment of knowledge regarding IVF treatment, with higher scores indicating a greater knowledge of IVF treatment, and lower scores indicating less knowledge regarding IVF treatment |
From enrollment to 2-4 days after oocyte retrieval
|
|
Likelihood of continued IVF treatment in the instance of a negative pregnancy test
Periodo de tiempo: Three months after embryo transfer
|
Patients who are not pregnant after embryo transfer will be followed for three months to assess likelihood to return for additional treatment after negative embryo transfer outcome. |
Three months after embryo transfer
|
|
Change in male fertility patient quality of life score during IVF treatment cycle
Periodo de tiempo: From enrollment to 2-4 days after oocyte retrieval
|
FertiQoL International (Fertility Quality of Life Questionnaire 2008), scored scale from 0-100, with higher values indicating a higher quality of life and low scores indicating a lower quality of life. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in male GAD-7 score during IVF treatment cycle
Periodo de tiempo: From enrollment to 2-4 days after oocyte retrieval
|
Generalized Anxiety Disorder 7-item scale, with higher scores indicating higher likelihood of an anxiety disorder and lower scores indicating less likelihood of an anxiety disorder. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in male PHQ-9 score during IVF treatment cycle
Periodo de tiempo: From enrollment to 2-4 days after oocyte retrieval
|
Patient Health Questionnaire, with higher score indicating increased likelihood of a depressive disorder and lower scores indicating less likelihood of a depressive disorder. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in male Connor-Davidson Resilience Scale during IVF treatment cycle
Periodo de tiempo: From enrollment to 2-4 days after oocyte retrieval
|
Connor-Davidson Resilience Scale, with higher scores indicating greater resilience, and lower scores indicating lower resilience |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in male knowledge assessment during IVF treatment cycle
Periodo de tiempo: From enrollment to 2-4 days after oocyte retrieval
|
Assessment of knowledge regarding IVF treatment, with higher scores indicating a greater knowledge of IVF treatment, and lower scores indicating less knowledge regarding IVF treatment |
From enrollment to 2-4 days after oocyte retrieval
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Rachel M Whynott, MD, University of Iowa
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Comportamiento
- Adherencia y Cumplimiento del Tratamiento
- Comportamiento de salud
- Aceptación del paciente de la atención médica
- Participación del paciente
- Satisfacción del paciente
- Administración de Servicios de Salud
- Calidad, acceso y evaluación de la atención médica
- Calidad de la atención médica
- Indicadores de calidad, atención médica
- Estándar de cuidado
Otros números de identificación del estudio
- 201906788
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .